Consolidated Statements Of Operations (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Net revenues:
Product revenue	$ 24,446,525	$ 25,575,276
Revenues, net	24,446,525	25,575,276
Costs and expenses:
Cost of goods sold	15,175,706	17,250,273
Marketing, general and administrative	10,024,089	10,678,655
Research and development	1,480,769	1,602,616
Goodwill Impairment	0	905,810
Total costs and expenses	26,680,564	30,437,354
Loss from operations	(2,234,039)	(4,862,078)
Other (expense) income:
Loss on disposal of assets	(86,885)	0
Equity in Ocular Telehealth Management, LLC	7,491	(70,393)
Interest income	137	240
Interest expense	(344,243)	(323,611)
Total other (expense) income	(423,500)	(393,764)
Net loss from continuing operations before taxes	(2,657,539)	(5,255,842)
Benefit of income taxes	0	(239,879)
Net (loss) from continuing operations	(2,657,539)	(5,015,963)
Net income from discontinued operations	(3,287,258)	(741,685)
Net loss	$ (5,944,797)	$ (5,757,648)
Basic:
Continuing operations	$ (0.35)	$ (0.67)
Discontinued operations	$ (0.44)	$ (0.10)
Net income (loss)	$ (0.79)	$ (0.77)
Diluted:
Continuing operations	$ (0.35)	$ (0.67)
Discontinued operations	$ (0.44)	$ (0.10)
Net income (loss)	$ (0.79)	$ (0.77)
Weighted average shares - basic	7,526,430	7,526,430
Weighted average shares - diluted	7,526,430	7,526,430